Cellebrite DI Ltd. Deferred Foreign Income Tax Expense (Benefit)
Cellebrite DI Ltd. (CLBT) reported Deferred Foreign Income Tax Expense (Benefit) of -$1.22 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-03-03
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$1.22M 20-F · filed 2026-03-03 |
| 2024-12-31 | -$417.00K 20-F · filed 2026-03-03 |
| 2023-12-31 | $3.81M 20-F · filed 2026-03-03 |
| 2022-12-31 | -$2.31M 20-F · filed 2025-03-18 |
| 2021-12-31 | -$1.63M 20-F · filed 2024-03-21 |
| 2020-12-31 | $911.00K 20-F · filed 2023-04-27 |
| 2019-12-31 | $230.00K 20-F · filed 2022-03-29 |